Hong Ge (H Ge)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Squamous Cell Carcinoma

Radiation Therapy

Endoplasmic Reticulum

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

Thoracic cancer

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaqiang Wang, Hong Ge, Zhichao Tian
Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism? OncoTargets and therapy 16 (2023)
Nengchao Wang, Yue Xu, Linzhi Jin, Xiaomin Wang, Shouxin Wu, Yu Wang, Jiangman Zhao, Fuyou Zhou, Hong Ge
Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma. Disease markers 2022 (2022)
Hui Luo, Liuxiang Wang, Deju Zhang, Yanan Sun, Shujuan Wang, Shuai Song, Hong Ge
HA15 inhibits BIP and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer science (2022)
Hui Luo, Liuxiang Wang, Deju Zhang, Yanan Sun, Shujuan Wang, Shuai Song, Hong Ge
HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer science (2022)
Xiaoli Zheng, Yanan Sun, Ke Ye, Chengcheng Fan, Xiaohui Wang, Yang Yang, Ruidi Jiao, Hong Ge
Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis. Thoracic cancer 12 (6) (2021)
Y Yang, H Luo, X L Zheng, Hong Ge
The optimal immune checkpoint inhibitors combined with chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (6) (2020)
Yang Yang, Hong Ge
Effective combinations of radiotherapy and immunotherapy in the treatment of esophageal squamous cell carcinoma. Future oncology (London, England) 16 (31) (2020)
Nan Wang, Xue Li, Hui Luo, Yanan Sun, Xiaoli Zheng, Chengcheng Fan, Hao Wang, Ke Ye, Hong Ge
Prognostic value of pretreatment inflammatory biomarkers in primary small cell carcinoma of the esophagus. Thoracic cancer 10 (10) (2019)
Hui Luo, Hengli Song, Ronghu Mao, Qiang Gao, Zhuo Feng, Nan Wang, Shuai Song, Ruidi Jiao, Peizan Ni, Hong Ge
Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer science 110 (11) (2019)
Hui Luo, Yingying Cui, Hengli Song, Ronghu Mao, Qiang Gao, Hong Ge
Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer? A systematic review and meta-analysis. Future oncology (London, England) 15 (26) (2019)
H Luo, Y Y Cui, J G Zhang, Y N Sun, X L Zheng, C L Yang, K Ye, Hong Ge
Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (7) (2017)